Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
2(66.7%)
Phase 2
1(33.3%)
3Total
Phase 1(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01172366Completed

A Study to Evaluate the Potential for Interpersonal Transfer of Testosterone Following Single Dose Application

Role: lead

NCT00996151Phase 1Completed

Testosterone MD-Lotion Residual Washing Study

Role: lead

NCT00857168Phase 1Completed

To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion

Role: lead

NCT00372008Phase 2Completed

Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males

Role: lead

All 4 trials loaded